Variability of hepatitis C virus

Peter Simmonds

doi:10.1002/hep.1840210243

. 2005 Dec 6;21(2):570–583. doi: 10.1002/hep.1840210243

Variability of hepatitis C virus

Peter Simmonds ^1,^✉

PMCID: PMC7165699 PMID: 7531173

The content is available as a PDF (1.8 MB).

References

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA derived from a blood‐borne non‐A, non‐B hepatitis genome. Science 1989; 244: 359–362. 2523562 [Google Scholar]
2. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T. et al. An assay for circulating antibodies to a major etiologic virus of human non‐A, non‐B hepatitis. Science 1989; 244: 362–364. [DOI] [PubMed] [Google Scholar]
3. Reyes GR, Purdy M, Kim JS, Luk KC, Young LM, Fry KE, Bradley DW. Isolation of cDNA from the virus responsible for enterically transmitted non‐A, non‐B hepatitis. Science 1990; 247: 1335–1339. [DOI] [PubMed] [Google Scholar]
4. Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C. et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A 1991; 88: 2451–2455. [DOI] [PMC free article] [PubMed] [Google Scholar]
5. Han JH, Shyamala V, Richman KH, Brauer MJ, Irvine B, Urdea MS, Tekamp Olson P, et al. Characterization of the terminal regions of hepatitis C viral RNA. identification of conserved sequences in the 5′ untranslated region and poly(A) tails at the 3′ end. Proc Natl Acad Sci U S A 1991; 88: 1711–1715. [DOI] [PMC free article] [PubMed] [Google Scholar]
6. Collett MS, Anderson DK, Retzel E. Comparisons of the pestivirus bovine viral diarrhoea virus with members of the flaviviridae. J Gen Virol 1988; 69: 2637–2643. [DOI] [PubMed] [Google Scholar]
7. Chambers TJ, Hahn CS, Galler R, Rice CM. Flavivirus genome organisation, expression and replication. Ann Rev Microbiol 1990; 44: 649–688. [DOI] [PubMed] [Google Scholar]
8. Miyamoto H, Okamoto H, Sato K, Tanaka T, Mishiro S. Extraordinarily low density of hepatitis C virus estimated by sucrose density gradient centrifugation and the polymerase chain reaction. J Gen Virol 1992; 73: 715–718. [DOI] [PubMed] [Google Scholar]
9. Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T, Shimotohno K. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non‐A, non‐B hepatitis. Proc Natl Acad Sci U S A 1990; 87: 9524–9528. [DOI] [PMC free article] [PubMed] [Google Scholar]
10. Takamizawa A, Mori C, Fuke I, Manabe S, Murakami S, Fujita J, Onishi E. et al. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 1991; 65: 1105–1113. [DOI] [PMC free article] [PubMed] [Google Scholar]
11. Okamoto H, Kurai K, Okada S, Yamamoto K, Lizuka H, Tanaka T, Fukuda S. et al. Full‐length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology 1992; 188: 331–341. [DOI] [PubMed] [Google Scholar]
12. Okamoto H, Okada S, Sugiyama Y, Kurai K, Iizuka H, Machida A, Miyakawa Y. et al. Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions. J Gen Virol 1991; 72: 2697–2704. [DOI] [PubMed] [Google Scholar]
13. Mori S, Kato N, Yagyu A, Tanaka T, Ikeda Y, Petchclai B, Chiewsilp P. et al. A new type of hepatitis C virus in patients in Thailand. Biochem Biophys Res Commun 1992; 183: 334–342. [DOI] [PubMed] [Google Scholar]
14. Chan S‐W, McOmish F, Holmes EC, Dow B, Peutherer JF, Follett E, Yap PL. et al. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol 1992; 73: 1131–1141. [DOI] [PubMed] [Google Scholar]
15. Enomoto N, Takada A, Nakao T, Date T. There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun 1990; 170: 1021–1025. [DOI] [PubMed] [Google Scholar]
16. Simmonds P, Holmes EC, Cha TA, Chan S‐W, McOmish F, Irvine B, Beall E. et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS‐5 region. J Gen Virol 1993; 74: 2391–2399. [DOI] [PubMed] [Google Scholar]
17. Simmonds P, McOmish F, Yap PL, Chan SW, Lin CK, Dusheiko G, Saeed AA. et al. Sequence variability in the 5′ non coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol 1993; 74: 661–668. [DOI] [PubMed] [Google Scholar]
18. Bukh J, Purcell RH, Miller RH. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proc Natl Acad Sci U S A 1993; 90: 8234–8238. [DOI] [PMC free article] [PubMed] [Google Scholar]
19. Simmonds P, Smith DB, McOmish F, Yap PL, Kolberg J, Urdea MS, Holmes EC. Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS‐5 regions. J Gen Virol 1994; 75: 1053–1061. [DOI] [PubMed] [Google Scholar]
20. Holmes EC, Simmonds P, Cha T‐A, Chan S‐W, McOmish F, Irvine B, Beall E, et al. Derivation of a rational nomenclature for hepatitis C virus by phylogenetic analysis of the NS‐5 region In: Nishioka K, Suzuki H, Mishiro S, Oda T. eds. Viral hepatitis and liver disease. Tokyo: Springer‐Verlag, 1994: 57–62. [Google Scholar]
21. Nakao T, Enomoto N, Takada N, Takada A, Date T. Typing of hepatitis C virus (HCV) genomes by restriction fragment length polymorphisms. J Gen Virol 1991; 72: 2105–2112. [DOI] [PubMed] [Google Scholar]
22. McOmish F, Chan S‐W, Dow BC, Gillon J, Frame WD, Crawford RJ, Yap PL. et al. Detection of three types of hepatitis C virus in blood donors: Investigation of type‐specific differences in serological reactivity and rate of alanine aminotransferase abnormalities. Transfusion 1993; 33: 7–13. [DOI] [PubMed] [Google Scholar]
23. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, Maertens G. Typing of hepatitis C virus isolates and characterisation of new subtypes using a line probe assay. J Gen Virol 1993; 74: 1093–1102. [DOI] [PubMed] [Google Scholar]
24. Okamoto H, Kojima M, Sakamoto M, Iizuka H, Hadiwandowo S, Suwignyo S, Miyakawa Y. et al. The entire nucleotide sequence and classification of a hepatitis C virus isolate of a novel genotype from an Indonesian patient with chronic liver disease. J Gen Virol 1994; 75: 629–635. [DOI] [PubMed] [Google Scholar]
25. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT. et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19 (suppl): 1321–1324. [PubMed] [Google Scholar]
26. Ogata N, Alter HJ, Miller RH, Purcell RH. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci U S A 1991; 88: 3392–3396. [DOI] [PMC free article] [PubMed] [Google Scholar]
27. Abe K, Inchauspe G, Fujisawa K. Genomic characterisation and mutation rate of hepatitis C virus isolated from a patient who contracted hepatitis during an epidemic on non‐A, non‐B hepatitis in Japan. J Gen Virol 1992; 73: 2725–2729. [DOI] [PubMed] [Google Scholar]
28. Okamoto H, Kojima M, Okada S‐I, Yoshizawa H, Iizuka H, Tanaka T, Muchmore EE. et al. Genetic drift of hepatitis C virus during an 8.2 year infection in a chimpanzee: variability and stability. Virology 1992; 190: 894–899. [DOI] [PubMed] [Google Scholar]
29. Cuypers HTM, Winkel IN, van der Poel CL, Reesink HW, Lelie PN, Houghton M, Weiner A. Analysis of genomic variability of hepatitis C virus. J Hepatol 1991; 13: S15–S19. [DOI] [PubMed] [Google Scholar]
30. Li W‐H, Graur D. Fundamentals of molecular evolution. New York: Sinaur Associates, Inc, 1991. [Google Scholar]
31. Nei M. Molecular evolutionary genetics. Sunderland, MA: Columbia University Press, 1987. [Google Scholar]
32. Tsukiyama Kohara K, Iizuka N, Kohara M, Nomoto A. Internal ribosome entry site within hepatitis C virus RNA. J Virol 1992; 66: 1476–1483. [DOI] [PMC free article] [PubMed] [Google Scholar]
33. Brown EA, Zhang H, Ping H‐L, Lemon SM. Secondary structure of the 5′ nontranslated region of hepatitis C virus and pestivirus genomic RNAs. Nucleic Acids Res 1992; 20: 5041–5045. [DOI] [PMC free article] [PubMed] [Google Scholar]
34. Wang CY, Sarnow P, Siddiqui A. Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome‐binding mechanism. J Virol 1993; 67: 3338–3344. [DOI] [PMC free article] [PubMed] [Google Scholar]
35. Ina Y, Mizokami M, Ohba K, Gojobori T. Reduction of synonymous substitutions in the core protein gene of hepatitis C virus. J Mol Evol 1994; 38: 50–56. [DOI] [PubMed] [Google Scholar]
36. Chan S‐W, Simmonds P, McOmish F, Yap P‐L, Mitchell R, Dow B, Follett E. Serological reactivity of blood donors infected with three different types of hepatitis C virus. Lancet 1991; 338: 1391. [DOI] [PubMed] [Google Scholar]
37. Li J, Tong S, Vitvitski L, Lepot D, Trepo C. Two French genotypes of hepatitis C virus: homology of the predominant genotype with the prototype American strain. Gene 1991; 105: 167–172. [DOI] [PubMed] [Google Scholar]
38. Lee C, Cheng C, Wang J, Lumeng L. Identification of hepatitis C viruses with a nonconserved sequence of the 5′ untranslated region. J Clin Microbiol 1992; 30: 1602–1604. [DOI] [PMC free article] [PubMed] [Google Scholar]
39. Bukh J, Purcell RH, Miller RH. Sequence analysis of the 5′ noncoding region of hepatitis C virus. Proc Natl Acad Sci U S A 1992; 89: 4942–4946. [DOI] [PMC free article] [PubMed] [Google Scholar]
40. Cha TA, Beall E, Irvine B, Kolberg J, Chien D, Kuo G, Urdea MS. At least five related, but distinct, hepatitis C viral genotypes exist. Proc Natl Acad Sci U S A 1992; 89: 7144–7148. [DOI] [PMC free article] [PubMed] [Google Scholar]
41. McOmish F, Yap PL, Dow BC, Follett EAC, Seed C, Keller AJ, Cobain TJ. et al. Geographical distribution of different hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 1994; 32: 884–892. [DOI] [PMC free article] [PubMed] [Google Scholar]
42. Kleter GEM, Van Doorn LJ, Brouwer JT, Schalm SW, Heijtink RA, Quint WGV. Sequence analysis of the 5′ untranslated region in isolates of at least four genotypes of hepatitis C virus in the Netherlands. J Clin Microbiol 1994; 33: 306–310. [DOI] [PMC free article] [PubMed] [Google Scholar]
43. Murphy D, Willems B, Delage G. Use of the 5′ non‐coding region for genotyping hepatitis C virus. J Infect Dis 1994; 169: 473–475. [DOI] [PubMed] [Google Scholar]
44. Tisminetzky SG, Gerotto M, Pontisso P, Chemello L, Ruvoletto MG, Baralle F, Alberti A. Genotypes of hepatitis C virus in italian patients with chronic hepatitis C. Int Hepatol Commun 1994; 2: 105–112. [Google Scholar]
45. Qu D, Hantz O, Gouy M, Vitvitski L, Li JS, Berby F, Tong SP. et al. Heterogeneity of hepatitis C virus genotypes in France. J Gen Virol 1994; 75: 1063–1070. [DOI] [PubMed] [Google Scholar]
46. Lau JYN, Mizokami M, Kolberg J, Davis GL, Prescott LE, Ohno T, Perrillo RP, et al. Application of hepatitis C virus genotyping systems in United States patients with chronic hepatitis C. J Infect Dis 1995. (in press). [DOI] [PubMed]
47. Saeed AA, al Admawi AM, al Rasheed A, Fairclough D, Bacchus R, Ring C, Garson J. Hepatitis C virus infection in Egyptian volunteer blood donors in Riyadh. Lancet 1991; 338: 459–460. [DOI] [PubMed] [Google Scholar]
48. Darwish MA, Raouf TA, Rushdy P, Constantine NT, Rao MR, Edelman R. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg 1993; 49: 440–447. [DOI] [PubMed] [Google Scholar]
49. Kamel MA, Ghaffar YA, Wasef MA, Wright M, Clark LC, Miller FD. High HCV prevalence in egyptian blood donors. Lancet 1992; 340: 427. [DOI] [PubMed] [Google Scholar]
50. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, Maertens G. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993; 74: 1093–1102. [DOI] [PubMed] [Google Scholar]
51. Delaporte E, Thiers V, Dazza MC, Romeo R, Mlikacabanne N, Aptel I, Schrijvers D. et al. High level of hepatitis C endemicity in Gabon, Equatorial Africa. Trans R Soc Trop Med Hyg 1993; 87: 636–637. [DOI] [PubMed] [Google Scholar]
52. Ohno T, Mizokami M, Tibbs CJ, Ohba K, Suzuki K, Wu RR, Nouriaria KT. et al. New genotype of hepatitis C virus in South‐Africa. J Med Virol 1994; 42: 409–413. [DOI] [PubMed] [Google Scholar]
53. Kato N, Ootsuyama Y, Ohkoshi S, Nakazawa T, Mori S, Hijikata M, Shimotohno K. Distribution of plural HCV types in Japan. Biochem Biophys Res Commun 1991; 181: 279–285. [DOI] [PubMed] [Google Scholar]
54. Takada N, Takase S, Enomoto N, Takada A, Date T. Clinical backgrounds of the patients having different types of hepatitis C virus genomes. J Hepatol 1992; 14: 35–40. [DOI] [PubMed] [Google Scholar]
55. Liu K, Hu Z, Li H, Prince AM, Inchauspe G. Genomic typing of hepatitis C viruses present in China. Gene 1992; 114: 245–250. [DOI] [PubMed] [Google Scholar]
56. Wang Y, Okamoto H, Mishiro S. HCV genotypes in China. Lancet 1992; 339: 1168. [DOI] [PubMed] [Google Scholar]
57. Takada N, Takase S, Takada A, Date T. HCV genotypes in different countries. Lancet 1992; 339: 808. [DOI] [PubMed] [Google Scholar]
58. Takada N, Takase S, Takada A, Date T. Differences in the hepatitis C virus genotypes in different countries. J Hepatol 1993; 17: 277–283. [DOI] [PubMed] [Google Scholar]
59. Wang Y, Okamoto H, Tsuda F, Nagayama R, Tao Q, Mishiro S. Prevalence, genotypes, and an isolate (HC‐C2) of hepatitis C virus in Chinese patients with liver disease. J Med Virol 1993; 40: 254–260. [DOI] [PubMed] [Google Scholar]
60. Kinoshita T, Miyake K, Okamoto H, Mishiro S. Imported hepatitis C virus genotypes in Japanese hemophilics. J Infect Dis 1993; 168: 249–250. [DOI] [PubMed] [Google Scholar]
61. Chayama K, Tsubota A, Arase Y, Saitoh S, Koida I, Ikeda K, Matsumoto T. et al. Genotypic subtyping of hepatitis C virus. J Gastroenterol Hepatol 1993; 8: 150–156. [DOI] [PubMed] [Google Scholar]
62. Tokita H, Shrestha SM, Okamoto H, Sakamoto M, Hirokita M, Iizuka H, Shrestha S. et al. Hepatitis C virus variants from Nepal with novel genotypes and their classification into the third major group. J Gen Virol 1994; 75: 931–936. [DOI] [PubMed] [Google Scholar]
63. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T. et al. Typing hepatitis C virus by polymerase chain reaction with type‐specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73: 673–679. [DOI] [PubMed] [Google Scholar]
64. Okamoto H, Tokita H, Sakamoto M, Horikita M, Kojima M, Iizuka H, Mishiro S. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 1993; 74: 2385–2390. [DOI] [PubMed] [Google Scholar]
65. Simmonds P, Rose KA, Graham S, Chan SW, McOmish F, Dow BC, Follett EAC. et al. Mapping of serotype‐specific, immunodominant epitopes in the NS‐4 region of hepatitis C virus (HCV)—use of type‐specific peptides to serologically differentiate infections with HCV type 1, type 2, and type 3. J Clin Microbiol 1993; 31: 1493–1503. [DOI] [PMC free article] [PubMed] [Google Scholar]
66. Tanaka T, Tsukiyama‐Kohara K, Yamaguchi K, Yagi S, Tanaka S, Hasegawa A, Ohta Y. et al. Significance of specific antibody assay for genotyping of hepatitis C virus. Hepatology 1994; 19: 1347–1353. [PubMed] [Google Scholar]
67. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y. et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon‐alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992; 16: 293–299. [DOI] [PubMed] [Google Scholar]
68. Hino K, Sainokami S, Shimoda K, Iino S, Wang Y, Okamoto H, Miyakawa Y, et al. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J Med Virol 1994; 42: 299–305. [DOI] [PubMed] [Google Scholar]
69. Piccinino F, Felaco FM, Aprea L, Messina V, Pasquale G, Sagnelli E. Non responders to interferon therapy among chronic hepatitis patients infected with hepatitis C virus. Arch Virol 1993; 8 (suppl): 257–263. [DOI] [PubMed] [Google Scholar]
70. Uchida T, Taira M, Shikata T, Moriyama M, Tanaka N, Okubo H, Arakawa Y. Histological difference between complete responders and non‐responders to interferon therapy of the livers of patients with chronic hepatitis C. Acta Pathol Jpn 1993; 43: 230–236. [DOI] [PubMed] [Google Scholar]
71. Perez R, Pravia R, Linares A, Rodriguez M, Lombrana JLS, Suarez A, Riestra S, et al. Response related factors in recombinant interferon‐alfa‐2b treatment of chronic hepatitis C. Gut 1993; 34 (suppl): S139–S140. [DOI] [PMC free article] [PubMed] [Google Scholar]
72. Tsubota A, Chayama K, Arase Y, Koida I, Saitoh S, Ikeda K, Iwasaki S, et al. Factors useful in predicting the response to interferon therapy in chronic hepatitis C. J Gastroenterol Hepatol 1993; 8: 535–539. [DOI] [PubMed] [Google Scholar]
73. Camps J, Crisostomo S, Garciagranero M, Riezuboj JI, Civeira MP, Prieto J. Prediction of the response of chronic hepatitis C to interferon‐alfa—a statistical analysis of pretreatment variables. Gut 1993; 34: 1714–1717. [DOI] [PMC free article] [PubMed] [Google Scholar]
74. Tsubota A, Chayama K, Ikeda K, Yasuji A, Koida I, Saitoh S, Hashimoto M. et al. Factors predictive of response to interferon‐alpha therapy in hepatitis C virus infection. Hepatology 1994; 19: 1088–1094. [PubMed] [Google Scholar]
75. Kanai K, Kako M, Okamoto H. HCV genotypes in chronic hepatitis C and response to interferon. Lancet 1992; 339: 1543. [DOI] [PubMed] [Google Scholar]
76. Kobayashi Y, Watanabe S, Konishi M, Yokoi M, Kakehashi R, Kaito M, Kondo M. et al. Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon‐beta. Hepatology 1993; 18: 1319–1325. [PubMed] [Google Scholar]
77. Dusheiko G, Schmilovitzweiss H, Brown D, McOmish F, Yap PL, Sherlock S, McIntyre N. et al. Hepatitis C virus genotypes—an investigation of type‐specific differences in geographic origin and disease. Hepatology 1994; 19: 13–18. [PubMed] [Google Scholar]
78. Chemello L, Alberti A, Rose K, Simmonds P. Hepatitis C serotype and response to interferon therapy. N Engl J Med 1994; 330: 143. [DOI] [PubMed] [Google Scholar]
79. Yamada G, Takahashi M, Miyamoto R, Tsuji T, Yoshizawa H, Okamoto H. Prediction of interferon effect in chronic hepatitis C by both quantification and genotyping of HCV‐RNA. Dig Dis Sci 1994; 39: 441–444. [DOI] [PubMed] [Google Scholar]
80. Chayama K, Arase Y, Koida I, Tsubota A, Saitoh S, Ikeda K, Matsumoto T, et al. Antiviral effect of lymphoblastoid interferon‐alpha on hepatitis C virus in patients with chronic hepatitis type C. J Gastroenterol Hepatol 1994; 9: 128–133. [DOI] [PubMed] [Google Scholar]
81. Lau JYN, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, Mizokami M, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341: 1501–1504. [DOI] [PubMed] [Google Scholar]
82. Kato N, Ootsuyama Y, Ohkoshi S, Nakazawa T, Sekiya H, Hijikata M, Shimotohno K. Characterization of hypervariable regions in the putative envelope protein of hepatitis C virus. Biochem Biophys Res Commun 1992; 189: 119–127. [DOI] [PubMed] [Google Scholar]
83. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F. et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci U S A 1992; 89: 3468–3472. [DOI] [PMC free article] [PubMed] [Google Scholar]
84. Kato N, Ootsuyama Y, Tanaka T, Nakagawa M, Nakazawa T, Muraiso K, Ohkoshi S. et al. Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. Virus Res 1992; 22: 107–123. [DOI] [PubMed] [Google Scholar]
85. Hijikawa M, Kato N, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimotohno K. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun 1991; 175: 220–228. [DOI] [PubMed] [Google Scholar]
86. Okamoto H, Kojima M, Okada SI, Yoshizawa H, Iizuka H, Tanaka T, Muchmore EE. et al. Genetic drift of hepatitis‐c virus during an 8.2‐year infection in a chimpanzee—variability and stability. Virology 1992; 190: 894–899. [DOI] [PubMed] [Google Scholar]
87. Kato N, Sekiya H, Ootsuyama Y, Nakazawa T, Hijikata M, Ohkoshi S, Shimotohno K. Humoral immune response to hypervariable region‐1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol 1993; 67: 3923–3930. [DOI] [PMC free article] [PubMed] [Google Scholar]
88. Lesniewski RR, Boardway KM, Casey JM, Desai SM, Devare SG, Leung TK, Mushahwar IK. Hypervariable 5′‐terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants. J Med Virol 1993; 40: 150–156. [DOI] [PubMed] [Google Scholar]
89. Taniguchi S, Okamoto H, Sakamoto M, Kojima M, Tsuda F, Tanaka T, Munekata E. et al. A structurally flexible and antigenically variable n‐terminal domain of the hepatitis C virus e2/NS1 protein—implication for an escape from antibody. Virology 1993; 195: 297–301. [DOI] [PubMed] [Google Scholar]
90. Okada S‐I, Akahane Y, Suzuki H, Okamoto H, Mishiro S. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viraemic patients. Hepatology 1992; 16: 619–624. [DOI] [PubMed] [Google Scholar]
91. Kumar U, Brown J, Monjardino J, Thomas HC. Sequence variation in the large envelope glycoprotein (E2/NS1) of hepatitis C virus during chronic infection. J Infect Dis 1993; 167: 726–730. [DOI] [PubMed] [Google Scholar]
92. Higashi Y, Kakumu S, Yoshioka K, Wakita T, Mizokami M, Ohba K, Ito Y. et al. Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology 1993; 197: 659–668. [DOI] [PubMed] [Google Scholar]
93. Chien DY, Choo QL, Ralston R, Spaete R, Tong M, Houghton M, Kuo G. Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet 1993; 342: 933. [DOI] [PubMed] [Google Scholar]
94. Hada H, Koide N, Hanafusa T, Sakaguchi K, Shinji T, Sasaki S, Oka T. et al. Detection by western blotting of an antibody to the hepatitis C virus E1 envelope protein in sera of patients with chronic liver disease. Acta Med Okayama 1992; 46: 365–370. [DOI] [PubMed] [Google Scholar]
95. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD. Intrahepatic cytotoxic T lymphocytes specific for hepatitis‐c virus in persons with chronic hepatitis. J Immunol 1992; 149: 3339–3344. [PubMed] [Google Scholar]
96. Koziel MJ, Dudley D, Afdhal N, Choo QL, Houghton M, Ralston R, Walker BD. Hepatitis C virus (HCV)‐specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol 1993; 67: 7522–7532. [DOI] [PMC free article] [PubMed] [Google Scholar]
97. Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK. et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992; 258: 135–140. [DOI] [PubMed] [Google Scholar]
98. Prince AM, Brotman B, Huima T, Pascual D, Jaffery M, Inchauspe G. Immunity in hepatitis C infection. J Infect Dis 1992; 165: 438–443. [DOI] [PubMed] [Google Scholar]
99. Lai ME, Mazzoleni AP, Argiolu F, De Virgilis S, Balestriesi A, Purcell RH, Cao A. et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 1994; 343: 388–390. [DOI] [PubMed] [Google Scholar]
100. Thomssen R, Bonk S, Thiele A. Density heterogeneities of hepatitis C virus in human sera due to the binding of beta‐lipoproteins and immunoglobulins. Med Microbiol Immunol 1993; 182: 329–334. [DOI] [PubMed] [Google Scholar]
101. Chan S‐W, Holmes EC, McOmish F, Follett E, Yap PL, Simmonds P. Phylogenetic analysis of a new, highly divergent HCV type (type 3): effect of sequence variability on serological responses to infection. Hepatitis C and related viruses [Abstract]. Molecular Virology and Pathogenesis, First Meeting. Venice, Italy, July 1992; Abstract D5: 73.
102. Houghton M, Weiner A, Han J, Kuo G, Choo QL. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 1991; 14: 381–388. [PubMed] [Google Scholar]
103. Machida A, Ohnuma H, Tsuda F, Munekata E, Tanaka T, Akahane Y, Okamoto H. et al. Two distinct subtypes of hepatitis C virus defined by antibodies directed to the putative core protein. Hepatology 1992; 16: 886–891. [DOI] [PubMed] [Google Scholar]
104. Inchauspe G, Zebedee S, Lee DH, Sugitani M, Nasoff M, Prince AM. Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates. Proc Natl Acad Sci U S A 1991; 88: 10292–10296. [DOI] [PMC free article] [PubMed] [Google Scholar]
105. Sakamoto M, Akahane Y, Tsuda F, Tanaka T, Woodfield DG, Okamoto H. The entire nucleotide sequence and characterization of a hepatitis C virus of genotype V/3a. J Gen Virol 1994; 75: 1761–1768. [DOI] [PubMed] [Google Scholar]

[bib1] 1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA derived from a blood‐borne non‐A, non‐B hepatitis genome. Science 1989; 244: 359–362. 2523562 [Google Scholar]

[bib2] 2. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T. et al. An assay for circulating antibodies to a major etiologic virus of human non‐A, non‐B hepatitis. Science 1989; 244: 362–364. [DOI] [PubMed] [Google Scholar]

[bib3] 3. Reyes GR, Purdy M, Kim JS, Luk KC, Young LM, Fry KE, Bradley DW. Isolation of cDNA from the virus responsible for enterically transmitted non‐A, non‐B hepatitis. Science 1990; 247: 1335–1339. [DOI] [PubMed] [Google Scholar]

[bib4] 4. Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C. et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A 1991; 88: 2451–2455. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib5] 5. Han JH, Shyamala V, Richman KH, Brauer MJ, Irvine B, Urdea MS, Tekamp Olson P, et al. Characterization of the terminal regions of hepatitis C viral RNA. identification of conserved sequences in the 5′ untranslated region and poly(A) tails at the 3′ end. Proc Natl Acad Sci U S A 1991; 88: 1711–1715. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib6] 6. Collett MS, Anderson DK, Retzel E. Comparisons of the pestivirus bovine viral diarrhoea virus with members of the flaviviridae. J Gen Virol 1988; 69: 2637–2643. [DOI] [PubMed] [Google Scholar]

[bib7] 7. Chambers TJ, Hahn CS, Galler R, Rice CM. Flavivirus genome organisation, expression and replication. Ann Rev Microbiol 1990; 44: 649–688. [DOI] [PubMed] [Google Scholar]

[bib8] 8. Miyamoto H, Okamoto H, Sato K, Tanaka T, Mishiro S. Extraordinarily low density of hepatitis C virus estimated by sucrose density gradient centrifugation and the polymerase chain reaction. J Gen Virol 1992; 73: 715–718. [DOI] [PubMed] [Google Scholar]

[bib9] 9. Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T, Shimotohno K. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non‐A, non‐B hepatitis. Proc Natl Acad Sci U S A 1990; 87: 9524–9528. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib10] 10. Takamizawa A, Mori C, Fuke I, Manabe S, Murakami S, Fujita J, Onishi E. et al. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 1991; 65: 1105–1113. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib11] 11. Okamoto H, Kurai K, Okada S, Yamamoto K, Lizuka H, Tanaka T, Fukuda S. et al. Full‐length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology 1992; 188: 331–341. [DOI] [PubMed] [Google Scholar]

[bib12] 12. Okamoto H, Okada S, Sugiyama Y, Kurai K, Iizuka H, Machida A, Miyakawa Y. et al. Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions. J Gen Virol 1991; 72: 2697–2704. [DOI] [PubMed] [Google Scholar]

[bib13] 13. Mori S, Kato N, Yagyu A, Tanaka T, Ikeda Y, Petchclai B, Chiewsilp P. et al. A new type of hepatitis C virus in patients in Thailand. Biochem Biophys Res Commun 1992; 183: 334–342. [DOI] [PubMed] [Google Scholar]

[bib14] 14. Chan S‐W, McOmish F, Holmes EC, Dow B, Peutherer JF, Follett E, Yap PL. et al. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol 1992; 73: 1131–1141. [DOI] [PubMed] [Google Scholar]

[bib15] 15. Enomoto N, Takada A, Nakao T, Date T. There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun 1990; 170: 1021–1025. [DOI] [PubMed] [Google Scholar]

[bib16] 16. Simmonds P, Holmes EC, Cha TA, Chan S‐W, McOmish F, Irvine B, Beall E. et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS‐5 region. J Gen Virol 1993; 74: 2391–2399. [DOI] [PubMed] [Google Scholar]

[bib17] 17. Simmonds P, McOmish F, Yap PL, Chan SW, Lin CK, Dusheiko G, Saeed AA. et al. Sequence variability in the 5′ non coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol 1993; 74: 661–668. [DOI] [PubMed] [Google Scholar]

[bib18] 18. Bukh J, Purcell RH, Miller RH. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proc Natl Acad Sci U S A 1993; 90: 8234–8238. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib19] 19. Simmonds P, Smith DB, McOmish F, Yap PL, Kolberg J, Urdea MS, Holmes EC. Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS‐5 regions. J Gen Virol 1994; 75: 1053–1061. [DOI] [PubMed] [Google Scholar]

[bib20] 20. Holmes EC, Simmonds P, Cha T‐A, Chan S‐W, McOmish F, Irvine B, Beall E, et al. Derivation of a rational nomenclature for hepatitis C virus by phylogenetic analysis of the NS‐5 region In: Nishioka K, Suzuki H, Mishiro S, Oda T. eds. Viral hepatitis and liver disease. Tokyo: Springer‐Verlag, 1994: 57–62. [Google Scholar]

[bib21] 21. Nakao T, Enomoto N, Takada N, Takada A, Date T. Typing of hepatitis C virus (HCV) genomes by restriction fragment length polymorphisms. J Gen Virol 1991; 72: 2105–2112. [DOI] [PubMed] [Google Scholar]

[bib22] 22. McOmish F, Chan S‐W, Dow BC, Gillon J, Frame WD, Crawford RJ, Yap PL. et al. Detection of three types of hepatitis C virus in blood donors: Investigation of type‐specific differences in serological reactivity and rate of alanine aminotransferase abnormalities. Transfusion 1993; 33: 7–13. [DOI] [PubMed] [Google Scholar]

[bib23] 23. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, Maertens G. Typing of hepatitis C virus isolates and characterisation of new subtypes using a line probe assay. J Gen Virol 1993; 74: 1093–1102. [DOI] [PubMed] [Google Scholar]

[bib24] 24. Okamoto H, Kojima M, Sakamoto M, Iizuka H, Hadiwandowo S, Suwignyo S, Miyakawa Y. et al. The entire nucleotide sequence and classification of a hepatitis C virus isolate of a novel genotype from an Indonesian patient with chronic liver disease. J Gen Virol 1994; 75: 629–635. [DOI] [PubMed] [Google Scholar]

[bib25] 25. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT. et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19 (suppl): 1321–1324. [PubMed] [Google Scholar]

[bib26] 26. Ogata N, Alter HJ, Miller RH, Purcell RH. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci U S A 1991; 88: 3392–3396. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib27] 27. Abe K, Inchauspe G, Fujisawa K. Genomic characterisation and mutation rate of hepatitis C virus isolated from a patient who contracted hepatitis during an epidemic on non‐A, non‐B hepatitis in Japan. J Gen Virol 1992; 73: 2725–2729. [DOI] [PubMed] [Google Scholar]

[bib28] 28. Okamoto H, Kojima M, Okada S‐I, Yoshizawa H, Iizuka H, Tanaka T, Muchmore EE. et al. Genetic drift of hepatitis C virus during an 8.2 year infection in a chimpanzee: variability and stability. Virology 1992; 190: 894–899. [DOI] [PubMed] [Google Scholar]

[bib29] 29. Cuypers HTM, Winkel IN, van der Poel CL, Reesink HW, Lelie PN, Houghton M, Weiner A. Analysis of genomic variability of hepatitis C virus. J Hepatol 1991; 13: S15–S19. [DOI] [PubMed] [Google Scholar]

[bib30] 30. Li W‐H, Graur D. Fundamentals of molecular evolution. New York: Sinaur Associates, Inc, 1991. [Google Scholar]

[bib31] 31. Nei M. Molecular evolutionary genetics. Sunderland, MA: Columbia University Press, 1987. [Google Scholar]

[bib32] 32. Tsukiyama Kohara K, Iizuka N, Kohara M, Nomoto A. Internal ribosome entry site within hepatitis C virus RNA. J Virol 1992; 66: 1476–1483. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib33] 33. Brown EA, Zhang H, Ping H‐L, Lemon SM. Secondary structure of the 5′ nontranslated region of hepatitis C virus and pestivirus genomic RNAs. Nucleic Acids Res 1992; 20: 5041–5045. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib34] 34. Wang CY, Sarnow P, Siddiqui A. Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome‐binding mechanism. J Virol 1993; 67: 3338–3344. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib35] 35. Ina Y, Mizokami M, Ohba K, Gojobori T. Reduction of synonymous substitutions in the core protein gene of hepatitis C virus. J Mol Evol 1994; 38: 50–56. [DOI] [PubMed] [Google Scholar]

[bib36] 36. Chan S‐W, Simmonds P, McOmish F, Yap P‐L, Mitchell R, Dow B, Follett E. Serological reactivity of blood donors infected with three different types of hepatitis C virus. Lancet 1991; 338: 1391. [DOI] [PubMed] [Google Scholar]

[bib37] 37. Li J, Tong S, Vitvitski L, Lepot D, Trepo C. Two French genotypes of hepatitis C virus: homology of the predominant genotype with the prototype American strain. Gene 1991; 105: 167–172. [DOI] [PubMed] [Google Scholar]

[bib38] 38. Lee C, Cheng C, Wang J, Lumeng L. Identification of hepatitis C viruses with a nonconserved sequence of the 5′ untranslated region. J Clin Microbiol 1992; 30: 1602–1604. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib39] 39. Bukh J, Purcell RH, Miller RH. Sequence analysis of the 5′ noncoding region of hepatitis C virus. Proc Natl Acad Sci U S A 1992; 89: 4942–4946. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib40] 40. Cha TA, Beall E, Irvine B, Kolberg J, Chien D, Kuo G, Urdea MS. At least five related, but distinct, hepatitis C viral genotypes exist. Proc Natl Acad Sci U S A 1992; 89: 7144–7148. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib41] 41. McOmish F, Yap PL, Dow BC, Follett EAC, Seed C, Keller AJ, Cobain TJ. et al. Geographical distribution of different hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 1994; 32: 884–892. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib42] 42. Kleter GEM, Van Doorn LJ, Brouwer JT, Schalm SW, Heijtink RA, Quint WGV. Sequence analysis of the 5′ untranslated region in isolates of at least four genotypes of hepatitis C virus in the Netherlands. J Clin Microbiol 1994; 33: 306–310. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib43] 43. Murphy D, Willems B, Delage G. Use of the 5′ non‐coding region for genotyping hepatitis C virus. J Infect Dis 1994; 169: 473–475. [DOI] [PubMed] [Google Scholar]

[bib44] 44. Tisminetzky SG, Gerotto M, Pontisso P, Chemello L, Ruvoletto MG, Baralle F, Alberti A. Genotypes of hepatitis C virus in italian patients with chronic hepatitis C. Int Hepatol Commun 1994; 2: 105–112. [Google Scholar]

[bib45] 45. Qu D, Hantz O, Gouy M, Vitvitski L, Li JS, Berby F, Tong SP. et al. Heterogeneity of hepatitis C virus genotypes in France. J Gen Virol 1994; 75: 1063–1070. [DOI] [PubMed] [Google Scholar]

[bib46] 46. Lau JYN, Mizokami M, Kolberg J, Davis GL, Prescott LE, Ohno T, Perrillo RP, et al. Application of hepatitis C virus genotyping systems in United States patients with chronic hepatitis C. J Infect Dis 1995. (in press). [DOI] [PubMed]

[bib47] 47. Saeed AA, al Admawi AM, al Rasheed A, Fairclough D, Bacchus R, Ring C, Garson J. Hepatitis C virus infection in Egyptian volunteer blood donors in Riyadh. Lancet 1991; 338: 459–460. [DOI] [PubMed] [Google Scholar]

[bib48] 48. Darwish MA, Raouf TA, Rushdy P, Constantine NT, Rao MR, Edelman R. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg 1993; 49: 440–447. [DOI] [PubMed] [Google Scholar]

[bib49] 49. Kamel MA, Ghaffar YA, Wasef MA, Wright M, Clark LC, Miller FD. High HCV prevalence in egyptian blood donors. Lancet 1992; 340: 427. [DOI] [PubMed] [Google Scholar]

[bib50] 50. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, Maertens G. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993; 74: 1093–1102. [DOI] [PubMed] [Google Scholar]

[bib51] 51. Delaporte E, Thiers V, Dazza MC, Romeo R, Mlikacabanne N, Aptel I, Schrijvers D. et al. High level of hepatitis C endemicity in Gabon, Equatorial Africa. Trans R Soc Trop Med Hyg 1993; 87: 636–637. [DOI] [PubMed] [Google Scholar]

[bib52] 52. Ohno T, Mizokami M, Tibbs CJ, Ohba K, Suzuki K, Wu RR, Nouriaria KT. et al. New genotype of hepatitis C virus in South‐Africa. J Med Virol 1994; 42: 409–413. [DOI] [PubMed] [Google Scholar]

[bib53] 53. Kato N, Ootsuyama Y, Ohkoshi S, Nakazawa T, Mori S, Hijikata M, Shimotohno K. Distribution of plural HCV types in Japan. Biochem Biophys Res Commun 1991; 181: 279–285. [DOI] [PubMed] [Google Scholar]

[bib54] 54. Takada N, Takase S, Enomoto N, Takada A, Date T. Clinical backgrounds of the patients having different types of hepatitis C virus genomes. J Hepatol 1992; 14: 35–40. [DOI] [PubMed] [Google Scholar]

[bib55] 55. Liu K, Hu Z, Li H, Prince AM, Inchauspe G. Genomic typing of hepatitis C viruses present in China. Gene 1992; 114: 245–250. [DOI] [PubMed] [Google Scholar]

[bib56] 56. Wang Y, Okamoto H, Mishiro S. HCV genotypes in China. Lancet 1992; 339: 1168. [DOI] [PubMed] [Google Scholar]

[bib57] 57. Takada N, Takase S, Takada A, Date T. HCV genotypes in different countries. Lancet 1992; 339: 808. [DOI] [PubMed] [Google Scholar]

[bib58] 58. Takada N, Takase S, Takada A, Date T. Differences in the hepatitis C virus genotypes in different countries. J Hepatol 1993; 17: 277–283. [DOI] [PubMed] [Google Scholar]

[bib59] 59. Wang Y, Okamoto H, Tsuda F, Nagayama R, Tao Q, Mishiro S. Prevalence, genotypes, and an isolate (HC‐C2) of hepatitis C virus in Chinese patients with liver disease. J Med Virol 1993; 40: 254–260. [DOI] [PubMed] [Google Scholar]

[bib60] 60. Kinoshita T, Miyake K, Okamoto H, Mishiro S. Imported hepatitis C virus genotypes in Japanese hemophilics. J Infect Dis 1993; 168: 249–250. [DOI] [PubMed] [Google Scholar]

[bib61] 61. Chayama K, Tsubota A, Arase Y, Saitoh S, Koida I, Ikeda K, Matsumoto T. et al. Genotypic subtyping of hepatitis C virus. J Gastroenterol Hepatol 1993; 8: 150–156. [DOI] [PubMed] [Google Scholar]

[bib62] 62. Tokita H, Shrestha SM, Okamoto H, Sakamoto M, Hirokita M, Iizuka H, Shrestha S. et al. Hepatitis C virus variants from Nepal with novel genotypes and their classification into the third major group. J Gen Virol 1994; 75: 931–936. [DOI] [PubMed] [Google Scholar]

[bib63] 63. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T. et al. Typing hepatitis C virus by polymerase chain reaction with type‐specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73: 673–679. [DOI] [PubMed] [Google Scholar]

[bib64] 64. Okamoto H, Tokita H, Sakamoto M, Horikita M, Kojima M, Iizuka H, Mishiro S. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 1993; 74: 2385–2390. [DOI] [PubMed] [Google Scholar]

[bib65] 65. Simmonds P, Rose KA, Graham S, Chan SW, McOmish F, Dow BC, Follett EAC. et al. Mapping of serotype‐specific, immunodominant epitopes in the NS‐4 region of hepatitis C virus (HCV)—use of type‐specific peptides to serologically differentiate infections with HCV type 1, type 2, and type 3. J Clin Microbiol 1993; 31: 1493–1503. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib66] 66. Tanaka T, Tsukiyama‐Kohara K, Yamaguchi K, Yagi S, Tanaka S, Hasegawa A, Ohta Y. et al. Significance of specific antibody assay for genotyping of hepatitis C virus. Hepatology 1994; 19: 1347–1353. [PubMed] [Google Scholar]

[bib67] 67. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y. et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon‐alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992; 16: 293–299. [DOI] [PubMed] [Google Scholar]

[bib68] 68. Hino K, Sainokami S, Shimoda K, Iino S, Wang Y, Okamoto H, Miyakawa Y, et al. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J Med Virol 1994; 42: 299–305. [DOI] [PubMed] [Google Scholar]

[bib69] 69. Piccinino F, Felaco FM, Aprea L, Messina V, Pasquale G, Sagnelli E. Non responders to interferon therapy among chronic hepatitis patients infected with hepatitis C virus. Arch Virol 1993; 8 (suppl): 257–263. [DOI] [PubMed] [Google Scholar]

[bib70] 70. Uchida T, Taira M, Shikata T, Moriyama M, Tanaka N, Okubo H, Arakawa Y. Histological difference between complete responders and non‐responders to interferon therapy of the livers of patients with chronic hepatitis C. Acta Pathol Jpn 1993; 43: 230–236. [DOI] [PubMed] [Google Scholar]

[bib71] 71. Perez R, Pravia R, Linares A, Rodriguez M, Lombrana JLS, Suarez A, Riestra S, et al. Response related factors in recombinant interferon‐alfa‐2b treatment of chronic hepatitis C. Gut 1993; 34 (suppl): S139–S140. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib72] 72. Tsubota A, Chayama K, Arase Y, Koida I, Saitoh S, Ikeda K, Iwasaki S, et al. Factors useful in predicting the response to interferon therapy in chronic hepatitis C. J Gastroenterol Hepatol 1993; 8: 535–539. [DOI] [PubMed] [Google Scholar]

[bib73] 73. Camps J, Crisostomo S, Garciagranero M, Riezuboj JI, Civeira MP, Prieto J. Prediction of the response of chronic hepatitis C to interferon‐alfa—a statistical analysis of pretreatment variables. Gut 1993; 34: 1714–1717. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib74] 74. Tsubota A, Chayama K, Ikeda K, Yasuji A, Koida I, Saitoh S, Hashimoto M. et al. Factors predictive of response to interferon‐alpha therapy in hepatitis C virus infection. Hepatology 1994; 19: 1088–1094. [PubMed] [Google Scholar]

[bib75] 75. Kanai K, Kako M, Okamoto H. HCV genotypes in chronic hepatitis C and response to interferon. Lancet 1992; 339: 1543. [DOI] [PubMed] [Google Scholar]

[bib76] 76. Kobayashi Y, Watanabe S, Konishi M, Yokoi M, Kakehashi R, Kaito M, Kondo M. et al. Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon‐beta. Hepatology 1993; 18: 1319–1325. [PubMed] [Google Scholar]

[bib77] 77. Dusheiko G, Schmilovitzweiss H, Brown D, McOmish F, Yap PL, Sherlock S, McIntyre N. et al. Hepatitis C virus genotypes—an investigation of type‐specific differences in geographic origin and disease. Hepatology 1994; 19: 13–18. [PubMed] [Google Scholar]

[bib78] 78. Chemello L, Alberti A, Rose K, Simmonds P. Hepatitis C serotype and response to interferon therapy. N Engl J Med 1994; 330: 143. [DOI] [PubMed] [Google Scholar]

[bib79] 79. Yamada G, Takahashi M, Miyamoto R, Tsuji T, Yoshizawa H, Okamoto H. Prediction of interferon effect in chronic hepatitis C by both quantification and genotyping of HCV‐RNA. Dig Dis Sci 1994; 39: 441–444. [DOI] [PubMed] [Google Scholar]

[bib80] 80. Chayama K, Arase Y, Koida I, Tsubota A, Saitoh S, Ikeda K, Matsumoto T, et al. Antiviral effect of lymphoblastoid interferon‐alpha on hepatitis C virus in patients with chronic hepatitis type C. J Gastroenterol Hepatol 1994; 9: 128–133. [DOI] [PubMed] [Google Scholar]

[bib81] 81. Lau JYN, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, Mizokami M, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341: 1501–1504. [DOI] [PubMed] [Google Scholar]

[bib82] 82. Kato N, Ootsuyama Y, Ohkoshi S, Nakazawa T, Sekiya H, Hijikata M, Shimotohno K. Characterization of hypervariable regions in the putative envelope protein of hepatitis C virus. Biochem Biophys Res Commun 1992; 189: 119–127. [DOI] [PubMed] [Google Scholar]

[bib83] 83. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F. et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci U S A 1992; 89: 3468–3472. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib84] 84. Kato N, Ootsuyama Y, Tanaka T, Nakagawa M, Nakazawa T, Muraiso K, Ohkoshi S. et al. Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. Virus Res 1992; 22: 107–123. [DOI] [PubMed] [Google Scholar]

[bib85] 85. Hijikawa M, Kato N, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimotohno K. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun 1991; 175: 220–228. [DOI] [PubMed] [Google Scholar]

[bib86] 86. Okamoto H, Kojima M, Okada SI, Yoshizawa H, Iizuka H, Tanaka T, Muchmore EE. et al. Genetic drift of hepatitis‐c virus during an 8.2‐year infection in a chimpanzee—variability and stability. Virology 1992; 190: 894–899. [DOI] [PubMed] [Google Scholar]

[bib87] 87. Kato N, Sekiya H, Ootsuyama Y, Nakazawa T, Hijikata M, Ohkoshi S, Shimotohno K. Humoral immune response to hypervariable region‐1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol 1993; 67: 3923–3930. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib88] 88. Lesniewski RR, Boardway KM, Casey JM, Desai SM, Devare SG, Leung TK, Mushahwar IK. Hypervariable 5′‐terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants. J Med Virol 1993; 40: 150–156. [DOI] [PubMed] [Google Scholar]

[bib89] 89. Taniguchi S, Okamoto H, Sakamoto M, Kojima M, Tsuda F, Tanaka T, Munekata E. et al. A structurally flexible and antigenically variable n‐terminal domain of the hepatitis C virus e2/NS1 protein—implication for an escape from antibody. Virology 1993; 195: 297–301. [DOI] [PubMed] [Google Scholar]

[bib90] 90. Okada S‐I, Akahane Y, Suzuki H, Okamoto H, Mishiro S. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viraemic patients. Hepatology 1992; 16: 619–624. [DOI] [PubMed] [Google Scholar]

[bib91] 91. Kumar U, Brown J, Monjardino J, Thomas HC. Sequence variation in the large envelope glycoprotein (E2/NS1) of hepatitis C virus during chronic infection. J Infect Dis 1993; 167: 726–730. [DOI] [PubMed] [Google Scholar]

[bib92] 92. Higashi Y, Kakumu S, Yoshioka K, Wakita T, Mizokami M, Ohba K, Ito Y. et al. Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology 1993; 197: 659–668. [DOI] [PubMed] [Google Scholar]

[bib93] 93. Chien DY, Choo QL, Ralston R, Spaete R, Tong M, Houghton M, Kuo G. Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet 1993; 342: 933. [DOI] [PubMed] [Google Scholar]

[bib94] 94. Hada H, Koide N, Hanafusa T, Sakaguchi K, Shinji T, Sasaki S, Oka T. et al. Detection by western blotting of an antibody to the hepatitis C virus E1 envelope protein in sera of patients with chronic liver disease. Acta Med Okayama 1992; 46: 365–370. [DOI] [PubMed] [Google Scholar]

[bib95] 95. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD. Intrahepatic cytotoxic T lymphocytes specific for hepatitis‐c virus in persons with chronic hepatitis. J Immunol 1992; 149: 3339–3344. [PubMed] [Google Scholar]

[bib96] 96. Koziel MJ, Dudley D, Afdhal N, Choo QL, Houghton M, Ralston R, Walker BD. Hepatitis C virus (HCV)‐specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol 1993; 67: 7522–7532. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib97] 97. Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK. et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992; 258: 135–140. [DOI] [PubMed] [Google Scholar]

[bib98] 98. Prince AM, Brotman B, Huima T, Pascual D, Jaffery M, Inchauspe G. Immunity in hepatitis C infection. J Infect Dis 1992; 165: 438–443. [DOI] [PubMed] [Google Scholar]

[bib99] 99. Lai ME, Mazzoleni AP, Argiolu F, De Virgilis S, Balestriesi A, Purcell RH, Cao A. et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 1994; 343: 388–390. [DOI] [PubMed] [Google Scholar]

[bib100] 100. Thomssen R, Bonk S, Thiele A. Density heterogeneities of hepatitis C virus in human sera due to the binding of beta‐lipoproteins and immunoglobulins. Med Microbiol Immunol 1993; 182: 329–334. [DOI] [PubMed] [Google Scholar]

[bib101] 101. Chan S‐W, Holmes EC, McOmish F, Follett E, Yap PL, Simmonds P. Phylogenetic analysis of a new, highly divergent HCV type (type 3): effect of sequence variability on serological responses to infection. Hepatitis C and related viruses [Abstract]. Molecular Virology and Pathogenesis, First Meeting. Venice, Italy, July 1992; Abstract D5: 73.

[bib102] 102. Houghton M, Weiner A, Han J, Kuo G, Choo QL. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 1991; 14: 381–388. [PubMed] [Google Scholar]

[bib103] 103. Machida A, Ohnuma H, Tsuda F, Munekata E, Tanaka T, Akahane Y, Okamoto H. et al. Two distinct subtypes of hepatitis C virus defined by antibodies directed to the putative core protein. Hepatology 1992; 16: 886–891. [DOI] [PubMed] [Google Scholar]

[bib104] 104. Inchauspe G, Zebedee S, Lee DH, Sugitani M, Nasoff M, Prince AM. Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates. Proc Natl Acad Sci U S A 1991; 88: 10292–10296. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib105] 105. Sakamoto M, Akahane Y, Tsuda F, Tanaka T, Woodfield DG, Okamoto H. The entire nucleotide sequence and characterization of a hepatitis C virus of genotype V/3a. J Gen Virol 1994; 75: 1761–1768. [DOI] [PubMed] [Google Scholar]

PERMALINK

Variability of hepatitis C virus

Peter Simmonds, MD

References

ACTIONS

PERMALINK

RESOURCES

Cite

Add to Collections

PERMALINK

Variability of hepatitis C virus

Peter Simmonds, MD

References

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases